BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35963019)

  • 1. Metabolic profiling of HIV infected individuals on an AZT-based antiretroviral treatment regimen reveals persistent oxidative stress.
    Sitole L; Fortuin R; Tugizimana F
    J Pharm Biomed Anal; 2022 Oct; 220():114986. PubMed ID: 35963019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-platform metabonomics unravel amino acids as markers of HIV/combination antiretroviral therapy-induced oxidative stress.
    Sitole LJ; Tugizimana F; Meyer D
    J Pharm Biomed Anal; 2019 Nov; 176():112796. PubMed ID: 31398507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raman-based metabonomics unravels metabolic changes related to a first-line tenofovir-based treatment in a small cohort of South African HIV-infected patients.
    Gabazana Z; Sitole L
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 248():119256. PubMed ID: 33310612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.
    Kim AH; Jang W; Kim Y; Park YJ; Han K; Oh EJ
    J Clin Lab Anal; 2013 Sep; 27(5):373-8. PubMed ID: 24038222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.
    Gibson RM; Nickel G; Crawford M; Kyeyune F; Venner C; Nankya I; Nabulime E; Ndashimye E; Poon AFY; Salata RA; Kityo C; Mugyenyi P; Quiñones-Mateu ME; Arts EJ
    Infect Dis Poverty; 2017 Dec; 6(1):163. PubMed ID: 29202874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabonomic analysis of HIV-infected biofluids.
    Sitole LJ; Williams AA; Meyer D
    Mol Biosyst; 2013 Jan; 9(1):18-28. PubMed ID: 23114495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.
    Kumar S; Batra H; Singh S; Chawla H; Singh R; Katpara S; Hussain AW; Das BK; Lodha R; Kabra SK; Luthra K
    J Gen Virol; 2020 Dec; 101(12):1289-1299. PubMed ID: 32915123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.
    Domingo P; Sambeat MA; Pérez A; Ordoñez J; Rodriguez J; Vázquez G
    Antivir Ther; 2003 Jun; 8(3):223-31. PubMed ID: 12924539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.
    Peltenburg NC; Schoeman JC; Hou J; Mora F; Harms AC; Lowe SH; Bierau J; Bakker JA; Verbon A; Hankemeier T; Boonstra A
    Sci Rep; 2018 Nov; 8(1):16947. PubMed ID: 30446683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
    Li T; Guo F; Li Y; Zhang C; Han Y; Lye W; He Y; Lu H; Xie J; Huang A; Li Y; Tang X; Wang H; Zhang T; Gao G; Lei J; Zhang X; Wu X; Sun Y; Bai J; Luo L; Wang H
    Chin Med J (Engl); 2014; 127(1):59-65. PubMed ID: 24384425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
    Sundaram M; Saghayam S; Priya B; Venkatesh KK; Balakrishnan P; Shankar EM; Murugavel KG; Solomon S; Kumarasamy N
    Int J Infect Dis; 2008 Nov; 12(6):e61-6. PubMed ID: 18621564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine.
    Bailey H; Townsend CL; Semenenko I; Malyuta R; Cortina-Borja M; Thorne C;
    Bull World Health Organ; 2013 Jul; 91(7):491-500. PubMed ID: 23825876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.
    Awadu JE; Sikorskii A; Zalwango S; Coventry A; Giordani B; Ezeamama AE
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.
    Msoka TF; Van Guilder GP; Smulders YM; van Furth M; Bartlett JA; van Agtmael MA
    BMC Infect Dis; 2018 Dec; 18(1):708. PubMed ID: 30594160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Combined Antiretroviral Therapy on Metabolic Syndrome Components in Adult People Living with HIV: A Literature Review.
    Sapuła M; Suchacz M; Załęski A; Wiercińska-Drapało A
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
    Kiage JN; Heimburger DC; Nyirenda CK; Wellons MF; Bagchi S; Chi BH; Koethe JR; Arnett DK; Kabagambe EK
    Lipids Health Dis; 2013 Apr; 12():50. PubMed ID: 23575345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.